Mechanism of the antimineralocorticoid effects of spirolactones (Q40318469)

19 September 2017

1 reference

title

Mechanism of the antimineralocorticoid effects of spirolactones (English)

1 reference

19 September 2017

Corvol P

1

1 reference

19 September 2017

Claire M

2

1 reference

19 September 2017

Oblin ME

3

1 reference

19 September 2017

Geering K

4

1 reference

19 September 2017

Rossier B

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 July 1981

1 reference

19 September 2017

1 reference

19 September 2017

volume

20

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

1-6

1 reference

Stimulation of aldosterone production in vitro and its inhibition by spironolactone

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Mechanism of action of steroid hormones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

The effect of sodium-retaining corticoid, electrocortin, desoxycorticosterone, and cortisone on renal function and excretion of sodium and water in adrenalectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

The metabolic effects of progesterone in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Abiological method for determining small quantities of sodium retaining substances

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

The physiological response to aldosterone in adrenalectomized and intact rats and its sex dependence

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Mechanism of the metabolic acidosis of selective mineralocorticoid deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Stimulation of urinary acidification by aldosterone and inhibitors of RNA and protein synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Spironolactone. An aldosterone agonist in the stimulation of H+ secretion by turtle urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

The effect of a new anti-aldosterone agent SC19886 on aldosterone-stimulated transepithelial sodium transport

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Thyroid hormone-aldosterone interaction on Na+ transport in toad bladder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Spironolactone antagonism of aldosterone action on Na+ transport and RNA metabolism in toad bladder epithelium

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Agonist and antimineralocorticoid activities of spirolactones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Importance of the lactonic ring in the activity of steroidal antialdosterones

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Effect of ADH, aldosterone, ouabain, and amiloride on toad bladder epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Subcellular mechanisms in the action of adrenal steroids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Aldosterone receptor occupancy and sodium transport in the urinary bladder of Bufo marinus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Binding of aldosterone to cytoplasmic and nuclear receptors of the urinary bladder epithelium of Bufo marinus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Studies on the binding of aldosterone in the toad bladder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Localization of physiological receptor sites for aldosteone in the bladder of the toad, Bufo marinus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Mechanism of Action of a New Antialdosterone Compound, Prorenone*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Spironolactone. I. Disposition and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Canrenone--the principal active metabolite of spironolactone?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Comparative effects of canrenoate-k and prorenoate-k upon aldosterone biosynthesis in perifused frog interrenal glands

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Spironolactone and Testicular Cytochrome P-450: Decreased Testosterone Formation inSeveral Species and Changes in Hepatic Drug Metabolism1

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Selective inhibition of aldosterone synthesis by 11-hydroxylated spirolactone in rat adrenals

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Effect of Spironolactone on Aldosterone Regulation in Man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Antiandrogenic Effect of Spirolactones: Mechanism of Action

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Mode of spironolactone anti-androgenic action: inhibition of androstanolone binding to rat prostate androgen receptor.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Gynecomastia induced in normal males by spironolactone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Pathophysiology of spironolactone-induced gynecomastia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.97

7 January 2021

Identifiers

DOI

10.1038/KI.1981.97

1 reference

19 September 2017

1 reference